Atlas Trials

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

Clinical trial NCT01432483 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT01432483
Sponsor
Eisai Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.